Arthritis Research & Therapy (Sep 2024)

Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study

  • Damiano Currado,
  • Francesca Saracino,
  • Piero Ruscitti,
  • Annalisa Marino,
  • Ilenia Pantano,
  • Marta Vomero,
  • Onorina Berardicurti,
  • Viktoriya Pavlych,
  • Claudio Di Vico,
  • Francesco Caso,
  • Luisa Costa,
  • Marco Tasso,
  • Federica Camarda,
  • Francesca Misceo,
  • Francesco De Vincenzo,
  • Addolorata Corrado,
  • Luisa Arcarese,
  • Amelia Rigon,
  • Marta Vadacca,
  • Erika Corberi,
  • Lyubomyra Kun,
  • Francesca Trunfio,
  • Andrea Pilato,
  • Ludovica Lamberti,
  • Francesco Paolo Cantatore,
  • Federico Perosa,
  • Giuliana Guggino,
  • Raffaele Scarpa,
  • Paola Cipriani,
  • Francesco Ciccia,
  • Roberto Giacomelli,
  • Luca Navarini

DOI
https://doi.org/10.1186/s13075-024-03396-5
Journal volume & issue
Vol. 26, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background Chronic pain and inflammation are common features of rheumatic conditions such as Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (axSpA), often needing prolonged medication treatment for effective management. Maintaining drug retention is essential for both achieving disease control and improving patients' quality of life. This study investigates the influence of pain catastrophizing, a psychological response to pain, on the drug retention rates of PsA and axSpA patients. Methods A two-year prospective multicenter observational study involved 135 PsA and 71 axSpA patients. Pain Catastrophizing Scale (PCS) was employed to assess pain catastrophizing. Univariable and multivariable regression analyses were utilized to identify factors associated with drug retention. Results In the PsA group, patients early discontinuing therapy showed higher baseline disease activity as well as higher incidence of comorbid fibromyalgia. Notably, pain catastrophizing, specifically the domains of Helplessness, Magnification, and Rumination, were significantly elevated in PsA patients who interrupted the treatment. Multivariable analysis confirmed pain catastrophizing as an independent predictor of drug suspension within two years. In axSpA, drug discontinuation was associated with female gender, shorter disease duration, higher baseline disease activity as well as elevated levels of pain catastrophizing. Univariable analysis supported the role of pain catastrophizing, including its domains, as predictors of treatment interruption. However, limited events in axSpA patients precluded a multivariate analysis. Conclusion This prospective study emphasizes the impact of pain catastrophizing on drug retention in patients with PsA and axSpA.

Keywords